N-[1-[4-[[4-[[4-[4-[[(6aS)-2-methoxy-12-oxo-7,8,9,10-tetrahydro-6aH-pyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indol-5-yl]-(2-methoxyethoxy)phosphonamidic acid

C46H52N11O11P — CID 170261313

IUPACN-[1-[4-[[4-[[4-[4-[[(6aS)-2-methoxy-12-oxo-7,8,9,10-tetrahydro-6aH-pyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indol-5-yl]-(2-methoxyethoxy)phosphonamidic acid
SMILESCOCCOP(=O)(O)Nc1ccc2c(ccn2C(=O)c2cc(NC(=O)c3cc(NC(=O)c4nc(NC(=O)CCCOc5cc6c(cc5OC)C(=O)N5CCCC[C@H]5C=N6)cn4C)cn3C)cn2C)c1
InChIInChI=1S/C46H52N11O11P/c1-53-25-30(20-36(53)43(59)48-31-21-37(54(2)26-31)46(62)57-15-13-28-19-29(11-12-35(28)57)52-69(63,64)68-18-17-65-4)49-44(60)42-51-40(27-55(42)3)50-41(58)10-8-16-67-39-23-34-33(22-38(39)66-5)45(61)56-14-7-6-9-32(56)24-47-34/h11-13,15,19-27,32H,6-10,14,16-18H2,1-5H3,(H,48,59)(H,49,60)(H,50,58)(H2,52,63,64)/t32-/m0/s1
InChIKeyWJPDFAOSEYZXMJ-YTTGMZPUSA-N
MW965.96 g/mol
LogP5.94
Rot. Bonds18

About N-[1-[4-[[4-[[4-[4-[[(6aS)-2-methoxy-12-oxo-7,8,9,10-tetrahydro-6aH-pyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indol-5-yl]-(2-methoxyethoxy)phosphonamidic acid

N-[1-[4-[[4-[[4-[4-[[(6aS)-2-methoxy-12-oxo-7,8,9,10-tetrahydro-6aH-pyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indol-5-yl]-(2-methoxyethoxy)phosphonamidic acid (PubChem CID 170261313) has the molecular formula C46H52N11O11P and a molecular weight of 965.96 g/mol. Its IUPAC name is N-[1-[4-[[4-[[4-[4-[[(6aS)-2-methoxy-12-oxo-7,8,9,10-tetrahydro-6aH-pyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indol-5-yl]-(2-methoxyethoxy)phosphonamidic acid.

Molecular Properties

Compound NameN-[1-[4-[[4-[[4-[4-[[(6aS)-2-methoxy-12-oxo-7,8,9,10-tetrahydro-6aH-pyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indol-5-yl]-(2-methoxyethoxy)phosphonamidic acid
PubChem CID170261313
Molecular FormulaC46H52N11O11P
Molecular Weight965.96 g/mol
Exact Mass965.36
IUPAC NameN-[1-[4-[[4-[[4-[4-[[(6aS)-2-methoxy-12-oxo-7,8,9,10-tetrahydro-6aH-pyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indol-5-yl]-(2-methoxyethoxy)phosphonamidic acid
SMILESCOCCOP(=O)(O)Nc1ccc2c(ccn2C(=O)c2cc(NC(=O)c3cc(NC(=O)c4nc(NC(=O)CCCOc5cc6c(cc5OC)C(=O)N5CCCC[C@H]5C=N6)cn4C)cn3C)cn2C)c1
InChIInChI=1S/C46H52N11O11P/c1-53-25-30(20-36(53)43(59)48-31-21-37(54(2)26-31)46(62)57-15-13-28-19-29(11-12-35(28)57)52-69(63,64)68-18-17-65-4)49-44(60)42-51-40(27-55(42)3)50-41(58)10-8-16-67-39-23-34-33(22-38(39)66-5)45(61)56-14-7-6-9-32(56)24-47-34/h11-13,15,19-27,32H,6-10,14,16-18H2,1-5H3,(H,48,59)(H,49,60)(H,50,58)(H2,52,63,64)/t32-/m0/s1
InChIKeyWJPDFAOSEYZXMJ-YTTGMZPUSA-N
XLogP5.94
TPSA255.90 Ų
H-Bond Donors5
H-Bond Acceptors16
Rotatable Bonds18
Heavy Atoms69
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500965.96
LogP ≤ 55.94
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze N-[1-[4-[[4-[[4-[4-[[(6aS)-2-methoxy-12-oxo-7,8,9,10-tetrahydro-6aH-pyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indol-5-yl]-(2-methoxyethoxy)phosphonamidic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[1-[4-[[4-[[4-[4-[[(6aS)-2-methoxy-12-oxo-7,8,9,10-tetrahydro-6aH-pyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indol-5-yl]-(2-methoxyethoxy)phosphonamidic acid?
The IUPAC name of N-[1-[4-[[4-[[4-[4-[[(6aS)-2-methoxy-12-oxo-7,8,9,10-tetrahydro-6aH-pyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indol-5-yl]-(2-methoxyethoxy)phosphonamidic acid (CID 170261313) is N-[1-[4-[[4-[[4-[4-[[(6aS)-2-methoxy-12-oxo-7,8,9,10-tetrahydro-6aH-pyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indol-5-yl]-(2-methoxyethoxy)phosphonamidic acid.
What is the SMILES notation for N-[1-[4-[[4-[[4-[4-[[(6aS)-2-methoxy-12-oxo-7,8,9,10-tetrahydro-6aH-pyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indol-5-yl]-(2-methoxyethoxy)phosphonamidic acid?
The canonical SMILES for N-[1-[4-[[4-[[4-[4-[[(6aS)-2-methoxy-12-oxo-7,8,9,10-tetrahydro-6aH-pyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indol-5-yl]-(2-methoxyethoxy)phosphonamidic acid is COCCOP(=O)(O)Nc1ccc2c(ccn2C(=O)c2cc(NC(=O)c3cc(NC(=O)c4nc(NC(=O)CCCOc5cc6c(cc5OC)C(=O)N5CCCC[C@H]5C=N6)cn4C)cn3C)cn2C)c1.
What is the InChIKey of N-[1-[4-[[4-[[4-[4-[[(6aS)-2-methoxy-12-oxo-7,8,9,10-tetrahydro-6aH-pyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indol-5-yl]-(2-methoxyethoxy)phosphonamidic acid?
The InChIKey is WJPDFAOSEYZXMJ-YTTGMZPUSA-N. The full InChI is InChI=1S/C46H52N11O11P/c1-53-25-30(20-36(53)43(59)48-31-21-37(54(2)26-31)46(62)57-15-13-28-19-29(11-12-35(28)57)52-69(63,64)68-18-17-65-4)49-44(60)42-51-40(27-55(42)3)50-41(58)10-8-16-67-39-23-34-33(22-38(39)66-5)45(61)56-14-7-6-9-32(56)24-47-34/h11-13,15,19-27,32H,6-10,14,16-18H2,1-5H3,(H,48,59)(H,49,60)(H,50,58)(H2,52,63,64)/t32-/m0/s1.
What are the key properties of N-[1-[4-[[4-[[4-[4-[[(6aS)-2-methoxy-12-oxo-7,8,9,10-tetrahydro-6aH-pyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indol-5-yl]-(2-methoxyethoxy)phosphonamidic acid?
N-[1-[4-[[4-[[4-[4-[[(6aS)-2-methoxy-12-oxo-7,8,9,10-tetrahydro-6aH-pyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indol-5-yl]-(2-methoxyethoxy)phosphonamidic acid has a molecular weight of 965.96 g/mol, XLogP of 5.94, 18 rotatable bonds, 5 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1-[4-[[4-[[4-[4-[[(6aS)-2-methoxy-12-oxo-7,8,9,10-tetrahydro-6aH-pyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indol-5-yl]-(2-methoxyethoxy)phosphonamidic acid is sourced from PubChem (CID 170261313), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).